Literature DB >> 27928353

Invasive Fungal Sinusitis Involving the Orbital Apex in a Patient with Chronic Renal Failure.

Hyera Kang1, Yasuhiro Takahashi2, Kunihiro Nishimura3, Yuka Yamagishi4, Hiroshige Mikamo4, Hirohiko Kakizaki2.   

Abstract

An 82-year-old man with chronic renal failure presented with invasive fungal sinusitis involving the right orbital apex. Intravenous liposomal amphotericin B was immediately administered with an intravenous sodium supplement. Subsequently, endoscopic sinus surgery was performed. Aspergillus fumigatus was detected in nasal discharge culture on day 12. Because the patient's renal function had deteriorated by this time, therapy was changed to nasal inhalation of amphotericin B, which was discontinued after 1 month, and oral administration of voriconazole, which was discontinued after 2 months. During 6-month follow-up, the patient did not show recurrence of sinusitis or further decrease in renal function.

Entities:  

Keywords:  Liposomal amphotericin B; chronic renal failure; invasive fungal sinusitis; oral voriconazole; orbital apex

Year:  2015        PMID: 27928353      PMCID: PMC5122923          DOI: 10.3109/01658107.2015.1050113

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  8 in total

1.  Mortality and costs of acute renal failure associated with amphotericin B therapy.

Authors:  D W Bates; L Su; D T Yu; G M Chertow; D L Seger; D R Gomes; E J Dasbach; R Platt
Journal:  Clin Infect Dis       Date:  2001-02-21       Impact factor: 9.079

2.  Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome.

Authors:  Neelam Pushker; Rachna Meel; Seema Kashyap; Mandeep S Bajaj; Seema Sen
Journal:  Ophthalmology       Date:  2011-06-12       Impact factor: 12.079

Review 3.  Neuro-ophthalmology of invasive fungal sinusitis: 14 consecutive patients and a review of the literature.

Authors:  Matthew J Thurtell; Alison L S Chiu; Lucy A Goold; Gulden Akdal; John L Crompton; Rebekah Ahmed; Simon N Madge; Dinesh Selva; Ian Francis; Raf Ghabrial; Arj Ananda; John Gibson; Raymond Chan; Elizabeth O Thompson; Michael Rodriguez; Peter J McCluskey; G Michael Halmagyi
Journal:  Clin Exp Ophthalmol       Date:  2013-01-24       Impact factor: 4.207

4.  Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

Authors:  Raoul Herbrecht; David W Denning; Thomas F Patterson; John E Bennett; Reginald E Greene; Jörg-W Oestmann; Winfried V Kern; Kieren A Marr; Patricia Ribaud; Olivier Lortholary; Richard Sylvester; Robert H Rubin; John R Wingard; Paul Stark; Christine Durand; Denis Caillot; Eckhard Thiel; Pranatharthi H Chandrasekar; Michael R Hodges; Haran T Schlamm; Peter F Troke; Ben de Pauw
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

Review 5.  Toxicokinetic and mechanistic basis for the safety and tolerability of liposomal amphotericin B.

Authors:  Angela S Loo; Saif A Muhsin; Thomas J Walsh
Journal:  Expert Opin Drug Saf       Date:  2013-08-10       Impact factor: 4.250

6.  Orbital apex syndrome caused by invasive aspergillosis.

Authors:  Jin Won Kim; Min Seok Rha; Jeong Hong Kim; Ju Wan Kang
Journal:  J Craniofac Surg       Date:  2014       Impact factor: 1.046

Review 7.  Fungal rhinosinusitis: diagnosis and therapy.

Authors:  M S Schubert
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

8.  Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients.

Authors:  Marisa H Miceli; Pranatharthi Chandrasekar
Journal:  Infect Drug Resist       Date:  2012-01-11       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.